Structural Heart
LAAC devices and outcomes vs anticoagulation
Also called LAAC, LAA closure, Watchman, left atrial appendage
Sources: 12 new papers · 5 key papers · updated Oct 20, 2026
What 5 experts said about this trial's result
Expert labels are toward CHAMPION-AF's result, from named public quotes (n=5). As of Apr 7, 2026.
Unverified · drafted by AI from the sources cited below
The atrial appendage is an ear-shaped appendage of either atrium of the heart.1 Left atrial appendage occlusion reduces thromboembolic risk in patients with atrial fibrillation who have contraindications to oral anticoagulation.2
Accurate preprocedural imaging is essential for left atrial appendage occlusion device sizing.1 Non-contrast cardiac magnetic resonance can assess landing zone dimensions and morphology to predict optimal fluoroscopic projection angles.1
Left atrial appendage occlusion can be performed surgically or percutaneously.1 Percutaneous occlusion using Watchman or Amulet devices was shown to be non-inferior to non-warfarin oral anticoagulants for preventing major neurological, cardiovascular or bleeding events in a randomized trial of 402 patients with atrial fibrillation.2 Among 31,994 patients undergoing successful occlusion, common discharge medication strategies included warfarin and aspirin in 36.9% of cases.3 Device-related thrombus is considered an Achilles' heel of the procedure, and a registry of 711 patients found its presence was associated with a higher risk of ischemic stroke or systemic embolization.4
Beyond anticoagulation: defining the role of left atrial appendage closure in stroke prevention for atrial fibrillation
EP Europace — Camm A — Oct 2026
Left-sided 3D totally endoscopic mitral valve repair guided by left atrial appendage orientation in situs inversus totalis with mirror-image dextrocardia: a case report
BMC Cardiovascular Disorders — Wang Q — Sep 2026
4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation
Journal of the American College of Cardiology — Osmančík P
337 citations · 2021 · among the most cited on Left atrial appendage closure
Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion
Journal of the American College of Cardiology — Simard T
240 citations · 2021 · among the most cited on Left atrial appendage closure
Impact of Peridevice Leak on 5-Year Outcomes After Left Atrial Appendage Closure
Journal of the American College of Cardiology — Dukkipati S
145 citations · 2022 · among the most cited on Left atrial appendage closure
Antithrombotic Therapy After Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation
Journal of the American College of Cardiology — Freeman J
143 citations · 2022 · among the most cited on Left atrial appendage closure
A clinical question appears here only when its condition matches this topic, an outcome and a comparator were extracted from the studies, at least two studies and a patient count are on file, and the certainty is low or higher.
Supports benefit, no benefit shown, and mixed describe the direction of the measured effect. No benefit shown means the evidence does not support a benefit. It is not a finding of harm. Too little evidence means the question did not clear that bar.
Study count, RCT count, and patient count are separate. The patient total adds only studies that are linked into a study family and whose sample size is not flagged as implausible. A reversal is listed only when at least one randomized trial sits on each side of the change.
The overview is drafted from the guideline recommendations, trials, papers, and questions on this page, and every sentence has to cite one of them. It stays unverified until an NPI-verified clinician or a Synapse admin approves it. Approving records that person's name.
European Journal of Radiology — Wang Q — Aug 2026